Grants

2024

ribbon icon

TOGA Inspiration Research Grant: The application of a 3D cell culture model to assess the utility of novel immunotherapy drugs for the treatment of mesothelioma

Read more

Summary:

Funding Source: TOGA

Duration: 2 years

Contributors from ADDRI: Dr Peter (Huaikai) Shi

Role: CIA

Awarded: $50,000

2023

ribbon icon

Investigate gut microbiota influence on immunotherapy response in pleural mesothelioma mice model

Read more

Summary:

Funding Source: Trevor and Shirley Seaman

Duration: 2 years

Contributors from ADDRI: Dr Peter (Huaikai) Shi

Role: CIA

Awarded: $20,000

ribbon icon

Project Grant: Phase 1 study of Leptospermum polygalifolium extract in mesothelioma

Read more

Summary:

Funding Source: iCare

Duration: 3 years

Contributors from ADDRI: Dr Peter (Huaikai) Shi

Role: CIB

Awarded: $249,000

ribbon icon

Unlocking the potential of cancer associated fibroblasts to defeat pancreatic cancer Role: Chief investigator B

Read more

Summary:

NHMRC idea grant 2023

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Contributors: Kovacevic Z, Hosseini-Beheshti E

Awarded: $636,920

ribbon icon

Detecting metabolic changes in pancreatic fibroblasts prior to development of pancreatic cancer to facilitate early detection.

Read more

Summary:

PanKind 2023

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Contributors: Kovacevic Z, Timpson P, Hosseini-Beheshti E, Sahni S

Role: Chief investigator C

Awarded: $99,077

ribbon icon

Analysis of novel commercial innovation across the medical sciences and technology in a leading international intellectual property commercialisation company

Read more

Summary:

REDI Fellowship 2023

Analysis of novel commercial innovation across the medical sciences and technology in a leading international intellectual property commercialisation company

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Contributors: Perez S (IP Group)

Role: Chief investigator

Awarded: $200,633.40

ribbon icon

A novel approach to identify and treat mesothelioma

Read more

Summary:

2023 NSW Dust Diseases Authority (iCARE) Discovery Grant (2024-27). “A novel approach to identify and treat mesothelioma” AUD 249,520.00, Role: Co-Investigator

Contributors from ADDRI: Dr Anthony Linton

2022

ribbon icon

An AI-enhanced Multi-analyte Blood Test: The Next Generation of Breast Cancer Diagnostics  

Read more

Summary:

UNSW Social Good Seed Fund 2021 

An AI-enhanced Multi-analyte Blood Test: The Next Generation of Breast Cancer Diagnostics           

 

 

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Contributors: Project Supervisor: Fatemeh Vafaee

Role: Associate Investigator 

Awarded: $20,000

ribbon icon

Understanding the Role of Extracellular Vesicles in Mesothelioma Tumour Microenvironment

Read more

Summary:

Philanthropy
The Ruth Rose, David Doust and Debbie Brewer Gift
Understanding the Role of Extracellular Vesicles in Mesothelioma Tumour Microenvironment

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Role: Chief Investigator/CIA

Awarded: $120,000

ribbon icon

Extracellular Vesicles in Mesothelioma

Read more

Summary:

Donation: Turner Freeman Lawyer
Project Supervisor: Steven Kao, Elham Hosseini-Beheshti

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Role: Chief Investigator/CIA

Awarded: $25,000

ribbon icon

Development of a self-powered dye sensitized solar cell sensor as a point-of-care (POC) device for portable and fast extracellular vesicles (EV)-based cancer diagnosis

Read more

Summary:

USyd-UEdin Partnership Collaboration Awards

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Contributors: Project Supervisor: Elham Hosseini-Beheshti, Michael Xianfeng

Role: Chief Investigator A

Awarded: $20,000

ribbon icon

Commercial glucometer as a point-of-care device for early cancer screening

Read more

Summary:

Scottish Government SAPHIRE Grant: 2022

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Contributors: Project Supervisor: Michael Xianfeng

Role: Chief Investigator B

Awarded: $£10,000

2021

ribbon icon

High-throughput exosome sorting using affibody functionalized beads and inertial microfluidics

Read more

Summary:

Takeda Pharmaceutical Company Limited– COCKPI-T Funding 2020
Credit Share: 50:50
Investigators: Ebrahimi Warkiani M, Hosseini-Beheshti E.

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Role: Chief Investigator/CIB

Awarded: $100,000

ribbon icon

Extracellular Vesicles in Mesothelioma

Read more

Summary:

Turner Freeman Lawyer

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Contributors: Project Supervisor: Steven Kao, Elham Hosseini-Beheshti

Role: Chief Investigator/CIA

Awarded: $25,000

2020

ribbon icon

Is epigenetic alteration implicated in the treatment response of pembrolizumab?

Read more

Summary:

Funding Source: Dust Diseases Board

Duration: Two years

Contributors from ADDRI: A/Professor Steven Kao

Role: CIA

Awarded: $300,000

ribbon icon

Extracellular Vesicles, a Gateway to Precision medicine: immunotherapy in mesothelioma

Read more

Summary:

Funding Source: Dust Diseases Board

Duration: Two years

Contributors from ADDRI: A/Professor Steven Kao

Role: CIC

Awarded: $300,000

ribbon icon

An immune-chemo-microRNA approach to treat malignant pleural mesothelioma

Read more

Summary:

Funding Source: Tour de Cure

Duration: One year

Contributors from ADDRI: A/Professor Steven Kao

Role: CIA

Awarded: $50,000

ribbon icon

Project grant: Is epigenetic alteration implicated in the treatment response of pembrolizumab?

Read more

Summary:

Funding Source: iCare

Duration: 3 years

Contributors from ADDRI: Dr Peter (Huaikai) Shi

Role: CIC

Awarded: $277,800

ribbon icon

Project grant: WEE1 inhibitor and durvalumab to treat malignant pleural mesothelioma (MPM)

Read more

Summary:

Funding Source: AstraZeneca

Duration: 2 years

Contributors from ADDRI: Dr Peter (Huaikai) Shi

Role: CIC

Awarded: $86,000

ribbon icon

Extracellular Vesicles, a Gateway to Precision Medicine: Immunotherapy in Mesothelioma. 

Read more

Summary:

Funding Source: The Dust Disease Care Discovery

Credit Share: 100%

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Role: Chief Investigator/CIA

Awarded: $470,000

ribbon icon

Circular RNAs as potential biomarkers for malignant pleural mesothelioma

Read more

Summary:

NSW Dust Diseases Authority (iCARE) Discovery Grant (2021-23). “Circular RNAs as
potential biomarkers for malignant pleural mesothelioma.” AUD 295,000 Role: Co-
Investigator

Contributors from ADDRI: Dr Anthony Linton

2019

ribbon icon

Project grant: A novel 3D model for drug screening in mesothelioma

Read more

Summary:

Funding Source: iCare

Duration: 3 years

Contributors from ADDRI: Dr Peter (Huaikai) Shi

Role: CIC

Awarded: $300,000

ribbon icon

Identification of plasma extracellular vesicles signatures in lung cancer patients with brain metastases versus those without 

Read more

Summary:

Sydney Catalyst EnRICH   

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Contributors: Grau GE, Kao S, Hosseini-Beheshti E, Clark S.

Role: Chief Investigator/CIC      

Awarded: $65,000

ribbon icon

A novel regenerative therapy for treating osteoarthritis.

Read more

Summary:

Funding Source: Arthritis Australia Suzette Gateby Grant-in-Aid
Investigators: Li JJ, Hosseini-Beheshti E, Gentile C, Little C

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Role: Chief Investigator/CIB

Awarded: $15,000

ribbon icon

A new regenerative therapy for treating thumb base osteoarthritis.

Read more

Summary:

Funding Source: The Lincoln Centre Research Grant
Role:
Investigators: Li JJ, Hosseini-Beheshti E, Gentile C, Little C, Grau GE

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Role: Chief Investigator/CIB

Awarded: $31,397

ribbon icon

A novel 3D model for drug screening in mesothelioma

Read more

Summary:

NSW Dust Diseases Authority (iCARE) Discovery Grant (2020-22). “A novel 3D model for drug screening in mesothelioma” AUS 300,000. Role: Co-Investigator

Contributors from ADDRI: Dr Anthony Linton

Role: Co-Investigator

2018

ribbon icon

Predicting response to checkpoint therapy in lung cancer patients

Read more

Summary:

Funding Source: Cancer Council NSW

Duration: Five years

Contributors from ADDRI: A/Professor Steven Kao

Role: CIB

Awarded: $758,033.50

ribbon icon

A novel regenerative therapy for the treatment of osteoarthritis

Read more

Summary:

Lifespan Seed Grants, University of Sydney Awarded
A novel regenerative therapy for the treatment of osteoarthritis

 

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Contributors: Investigators: Li JJ E, Gentile C, Little C, Grau GE.

Role: Chief Investigator/CIB.

Awarded: $10,000

2015

ribbon icon

Expanding basic, clinical and functional genomic cancer research at Concord campus

Read more

Summary:

Funding Source: Cancer Institute NSW

Contributors from ADDRI: A/Professor Steven Kao

Role: CIH

Awarded: $385,470

ribbon icon

Do changes to chemotherapy dose and increased toxicity explain poorer survival outcomes in advanced cancer patients with systemic inflammation?

Read more

Summary:

Funding Source: Sydney Catalyst

Duration: One year

Contributors from ADDRI: A/Professor Steven Kao

Role: CIE

Awarded: $50,000

ribbon icon

Lung cancer cohort – a platform to study serial biospecimens and matched clinical data (LC-PLAT Study)

Read more

Summary:

Funding Source: Sydney Catalyst

Duration: One year

Contributors from ADDRI: A/Professor Steven Kao

Role: CIA

Awarded: $150,000

ribbon icon

Expanding the Asbestos Diseases Research Institute (ADRI) biobank to create a state-wide repository for research into thoracic cancers

Read more

Summary:

Funding Source: Cancer Institute NSW

Duration: Three Years

Contributors from ADDRI: A/Professor Steven Kao

Role: CIA

Awarded: $300,000

2014

ribbon icon

Multicentre Biobanking of advanced stage NSCLC – rapid onsite processing of fresh biopsy samples for comprehensive mutation testing and future studies

Read more

Summary:

Funding Source: Sydney Catalyst

Duration: One year

Contributors from ADDRI: A/Professor Steven Kao

Role: CIB

Awarded: $50,000

ribbon icon

Purification and characterization of exosomes derived from HP802 cells 

Read more

Summary:

Funding Source: Smith and Nephew

Contributors from ADDRI: Dr Elham Hosseini Beheshti

Contributors: Ghahary A., Tomlinson Guns ES.

Role: Associate Investigator. 

Awarded: $50,000

2013

ribbon icon

Implementing comprehensive next generation cancer mutation profiling in lung cancer

Read more

Summary:

Funding Source: Sydney Catalyst

Duration: One year

Contributors from ADDRI: A/Professor Steven Kao

Role: Associate Investigator

Awarded: $50,000

ribbon icon

Mutation profiling study of cancer genes in malignant pleural mesothelioma (MPM)

Read more

Summary:

Funding Source: Sydney Catalyst

Duration: 1 year

Contributors from ADDRI: A/Professor Steven Kao

Role: CIF

Awarded: $50,000

ribbon icon

Clinico-pathological correlation of patients with asbestos-related lung cancer versus non-asbestos-related lung cancer – cohorts from the Dust Diseases Board

Read more

Summary:

Funding Source: Pfizer

Duration: One year

Contributors from ADDRI: A/Professor Steven Kao

Role: CIA

Awarded: $50,000

2012

ribbon icon

Using proteomics to improve prognostication & prediction in malignant mesothelioma

Read more

Summary:

Funding Source: Dust Diseases Board

Duration: Two years

Contributors from ADDRI: A/Professor Steven Kao

Role: CIC

Awarded: $245,700

ribbon icon

Chemotherapy utilisation for malignant mesothelioma patients – optimal rate, barriers to access and patient preferences

Read more

Summary:

Funding Source: Dust Diseases Board

Duration: Two years

Contributors from ADDRI: A/Professor Steven Kao

Role: CIA

Awarded: $211,535

ribbon icon

Translating malignant mesothelioma research into better outcomes for patients and their families

Read more

Summary:

Funding Source: Cancer Institute NSW

Duration: Seven years

Contributors from ADDRI: A/Professor Steven Kao

Role: CID

Awarded: $3,500,000

2011

ribbon icon

Biaggio Signorelli Foundation Research Fellowship

Read more

Summary:

Biaggio Signorelli Foundation Research Fellowship (2011-2014) AUD 300,000. Fellowship Recipient

Contributors from ADDRI: Dr Anthony Linton

Awarded: $300,000

2010

ribbon icon

The role of Excision Repair Cross Complementation group 1 and Thymidylate Synthase expression in malignant pleural mesothelioma

Read more

Summary:

Funding Source: Cancer Institute NSW

Duration: Two years

Contributors from ADDRI: A/Professor Steven Kao

Awarded: $28,013

ribbon icon

Identification of predictive and prognostic factors in malignant mesothelioma

Read more

Summary:

Funding Source: NHMRC

Duration: Two years

Contributors from ADDRI: A/Professor Steven Kao

Role: Scholarship

Awarded: $73,913

2009

ribbon icon

A quantitative analysis of the DDB data set of applicants with a diagnosis of malignant mesothelioma (MM) from 2006-2007

Read more

Summary:

Funding Source: Dust Diseases Board

Duration: Two years

Contributors from ADDRI: A/Professor Steven Kao

Role: CIC

Awarded: $155,210

Sign up to our newsletter

Sign up
Skip to content